News|Articles|December 1, 2025

Which Cancer Therapies Were Approved by the FDA in November?

Fact checked by: Spencer Feldman, Tracy Ann Politowicz

Catch up on recent regulatory decisions by the FDA in oncology, including actions in lung, hematologic, genitourinary, and gastrointestinal cancers.

November was accompanied by a slew of FDA approvals across various tumor types, including multiple hematologic and lung cancers, along with an approval each in genitourinary and gastrointestinal cancers.